Characteristics of the First 102 Severe COVID-19 Cases Treated With Convalescent Plasma or Tocilizumab or Both in Al-Nahdha Hospital, Oman

• Egile Nagusiak: Saud Al Harthi (Egilea), Magdi Al Osali (Egilea), Nasser Al Kindi (Egilea), Zahir Al Kharusi (Egilea), Salim Al Qasabi (Egilea), Mohamed Al Hinai (Egilea), Thamra Al Ghafri (Egilea)
• Formatua: Liburua
• Argitaratua: SAGE Publishing, 2021-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: In the absence of an effective vaccine, the coronavirus disease (COVID-19) continues to cause more deaths. Evidence on the effectiveness of various COVID-19 management plans is inconclusive. This paper describes the characteristics of the first 102 severe COVID-19 in-patients treated wit...